Exposure to newer NSAIDs and older non-specific NSAIDs during the study period in study subjects from 369 study practices
| Period | Patient years* (‘000s) | No of events | Event rate (ptpy) |
|---|---|---|---|
| NSAIDs, non-steroidal anti-inflammatory drugs; ptpy, per thousand patient years. | |||
| *A total of 1 383 744 patients, all NSAID users, were included in the analysis. | |||
| †56% of exposure at 7.5 mg/day, 38% at 15 mg/day. | |||
| ‡Excludes exposure to aspirin alone. | |||
| Total | 6453 | 8526 | 1.32 |
| Before first exposure | 3136 | 2397 | 0.8 |
| Meloxicam† | 7.1 | 36 | 5.1 |
| Coxibs | 1.6 | 4 | 2.6 |
| Older non-specific NSAIDs‡ | 628 | 2875 | 4.6 |
| Post exposure | 2680 | 3214 | 1.2 |